Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2002Inflammatory Bowel Diseases

Infliximab Treatment for Crohn's Disease: One-Year Experience in a Dutch Academic Hospital

View Full Paper
Ask AI
Bookmark
Share

Authors

DHDaan W. HommesUniversity of California, Los AngelesBHBrenda H. van de HeisteegMSMirjam van der SpekAmsterdam UMC Location University of Amsterdam

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hommes et al. (2002) studied this question.

synapsesocial.com/papers/6a9fc0d7dfc81ffeb871de30https://doi.org/10.1097/00054725-200203000-00002
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease1999 · 2,766 citations
  2. 2Clinical Experience With Infliximab Therapy in 100 Patients With Crohn's Disease2000 · 212 citations
  3. 3Review article: targeting TNFα as a key cytokine in the inflammatory processes of Crohn’s disease — the mechanisms of action of infliximab1999 · 92 citations
  4. 4Immunotherapy of Crohn's Disease2000 · 41 citations